BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Prostate
,
Metabolism of nitric oxide
,
Acetaminophen
,
rs4950928
,
ERBB2
,
Hepatitis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
carcinoma in situ
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
TP53
CEACAM6
IGKC
IGHA1
JCHAIN
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
PILON_KLF1_TARGETS_DN
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
DODD_NASOPHARYNGEAL_CARCINOMA_DN
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
JOHNSTONE_PARVB_TARGETS_3_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Breast tumors with pathologic complete response (pCR) or residual disease (RD) upon chemotherapy
Cervical carcinoma HeLa and erythroleukemia TF-1 cells transfected with mutant and wildtype U2AF35
Ductal carcinoma in situ, invasive ductal carcinoma, and adjacent normal stromal cells
Skin (healthy and cancerous) of Rb KO (epidermis specific) and E2f1 KO mice
Cervical carcinoma HeLa S3 cells with shRNA knockdown of the transcription factor NF-YA
Explore Curated Studies Results
Literature
Most Relevant Literature
Utilizations and characteristics of ovarian conservation at hysterectomy for cervical carcinoma in s…
Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost?
Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost? - Authors' …
Intraductal Carcinoma: The Carcinoma In Situ of the Salivary Gland.
Shifting paradigms for the treatment of ductal carcinoma in situ: Less is more.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)
Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ
Genetics of Women With Lobular Carcinoma in Situ of the Breast
Effects of Diet and Exercise on Ductal Carcinoma in Situ
Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ